Get notified when LAB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Delisting (new) — Company received formal Nasdaq notice of non-compliance with minimum bid price requirement, triggering potential delisting process.
Standard BioTools receives Nasdaq delisting warning over $1 minimum stock price violation
Filed April 24, 2026 · Period ending September 13, 2025 · ~1 min read
Key Changes
-
high
Nasdaq notified Standard BioTools on April 20, 2026 that its stock failed to maintain the required $1.00 minimum bid price for 30 consecutive days, triggering a formal deficiency notice under listing rules.
Item 3.01 verify on EDGAR → -
high
Company has until October 19, 2026 (180 days) to regain compliance by closing at $1.00 or above for 10 consecutive trading days, or face potential delisting from Nasdaq Global Select Market.
Item 3.01 verify on EDGAR → -
high
If the company fails to meet the deadline, it may transfer to Nasdaq Capital Market for an additional 180 days or implement a reverse stock split to boost share price and regain compliance.
Item 3.01 verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CAG 10-K) is open in full — no account needed.
Partner
Trade LAB commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify